GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ourofino SA (BSP:OFSA3) » Definitions » Current Accrued Expense

Ourofino (BSP:OFSA3) Current Accrued Expense : R$0 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Ourofino Current Accrued Expense?

Ourofino's Current Accrued Expense for the quarter that ended in Mar. 2025 was R$0 Mil.

Ourofino Current Accrued Expense Historical Data

The historical data trend for Ourofino's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ourofino Current Accrued Expense Chart

Ourofino Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ourofino Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ourofino Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Ourofino Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Ourofino's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Ourofino Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ourofino SA (BSP:OFSA3) » Definitions » Current Accrued Expense
Comparable Companies
BSP:BLAU3 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538 TSE:4507 UTHR NSE:TORNTPHARM BOM:500124 NBIX BOM:543904
Traded in Other Exchanges
N/A
Address
Anhanguera Highway SP 330, Block C, 2nd floor, Km 298, Industrial District, Cravinhos, SP, BRA, 14140-000
Website
https://www.ourofino.com
Ourofino SA is engaged in research, development, production and sales of medicines, vaccines and other veterinary products. The company's reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimastitics, Biological, Ectoparasiticides, Endectocides, and others.

Ourofino Headlines

No Headlines